Cyclosporine Ophthalmic
545 interactions 1,631 cited referencesOphthalmic cyclosporine is used to increase tear production in people with dry eye disease. Cyclosporine is in a class of medications called immunomodulators. It works by decreasing swelling in the eye to allow for tear production. Read the full Cyclosporine Ophthalmic drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Moderate
Cyclosporine Ophthalmic Repaglinide Prandin® Increased repaglinide plasma concentrations Details Cyclosporine Ophthalmic Rilonacept Altered cycloSPORINE plasma concentrations Details Cyclosporine Ophthalmic Rilzabrutinib Wayrilz Increased P-gp substrate with NTI exposure and an increased risk of P-gp substrate with NTI-related adverse reactions Details Cyclosporine Ophthalmic Seladelpar Increased seladelpar exposure Details Cyclosporine Ophthalmic Sevelamer RenaGel Reduced efficacy of oral cyclosporine Details Cyclosporine Ophthalmic Sparsentan Filspari Increased sparsentan exposure and an increased cycloSPORINE exposure Details Cyclosporine Ophthalmic Stanozolol An increased risk of cycloSPORINE toxicity (renal dysfunction, cholestasis, paresthesias) Details Cyclosporine Ophthalmic Streptomycin Renal dysfunction or nephrotoxicity Details Cyclosporine Ophthalmic Sulfadiazine Microsulfon® Decreased cycloSPORINE effectiveness Details Cyclosporine Ophthalmic Sulfasalazine Azulfidine Loss of cycloSPORINE efficacy Details Cyclosporine Ophthalmic Tenofovir Alafenamide Increased tenofovir alafenamide or tenofovir disoproxil fumarate exposure Details Cyclosporine Ophthalmic Tenofovir Disoproxil Fumarate Increased tenofovir alafenamide or tenofovir disoproxil fumarate exposure Details Cyclosporine Ophthalmic Testosterone Androderm An increased risk of cycloSPORINE toxicity (renal dysfunction, cholestasis, paresthesias) Details Cyclosporine Ophthalmic Thalidomide Thalomid Increased cycloSPORINE A metabolism and clearance Details Cyclosporine Ophthalmic Tigecycline Tygacil May increase serum trough concentrations of calcineurin inhibitors Details Cyclosporine Ophthalmic Tinidazole Tindamax Increased levels of cycloSPORINE Details Cyclosporine Ophthalmic Tipranavir Aptivus Altered cycloSPORINE plasma concentrations Details Cyclosporine Ophthalmic Tolterodine Detrol Enhanced tolterodine bioavailability in individuals with deficient cytochrome P450 2D6 activity Details Cyclosporine Ophthalmic Troglitazone Decreased cycloSPORINE efficacy Details Cyclosporine Ophthalmic Vardenafil Levitra Increased vardenafil exposure Details Cyclosporine Ophthalmic Vincristine Marqibo Increased vinCRIStine plasma concentrations and risk of adverse reactions Details Cyclosporine Ophthalmic Vincristine Sulfate Liposome Marqibo Increased vinCRIStine plasma concentrations and risk of adverse reactions Details Cyclosporine Ophthalmic Xanomeline Increased oral sensitive CYP3A4 substrate that are P-gp substrates with NTI exposure and an increased risk on severity and frequen... Details Cyclosporine Ophthalmic Zofenopril Acute renal dysfunction DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist